Correlation of minimal residual disease (MRD) at the end of induction (EOI) and event free survival (EFS) in T-cell lymphoblastic lymphoma (T-LL), a report from the children's oncology group (COG) trial AALL1231 Meeting Abstract
| Authors: | Hayashi, R. J.; Hermiston, M. L.; Teachey, D. T.; Devidas, M.; Wood, B. L.; Chen, Z.; Annett, R. D.; Asselin, B. L.; August, K. J.; Cho, S. Y.; Dunsmore, K. P.; Freedman, J. L.; Galardy, P. J.; Harker-Murray, P.; Horton, T. M.; Jaju, A. I.; Lam, A.; Messinger, Y. H.; Miles, R. R.; Okada, M.; Patel, S. I.; Schafer, E. S.; Schechter-Finkelstein, T.; Shimano, K. A.; Singh, N.; Steele, A. C.; Sulis, M. L.; Vargas, S. L.; Winter, S. S.; Wood, C.; Zweidler-McKay, P. A.; Loh, M. L.; Hunger, S. P.; Raetz, E. A.; Bollard, C. M.; Allen, C. |
| Abstract Title: | Correlation of minimal residual disease (MRD) at the end of induction (EOI) and event free survival (EFS) in T-cell lymphoblastic lymphoma (T-LL), a report from the children's oncology group (COG) trial AALL1231 |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 6387 |
| End Page: | 6389 |
| Language: | English |
| ACCESSION: | WOS:000893223206178 |
| DOI: | 10.1182/blood-2022-159694 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
